7Indexed trials
drug · Product Intelligence
Brivaracetam
Pipeline Intelligence
Brivaracetam: 7 indexed trials, 5 sponsors; 0 linked Orange Book patents and 8 FDA-linked events where matched.
5Sponsors
0Orange Book patent links
8FDA-linked events
Development evidence
NCT00175825UCB Pharma · epilepsyPHASE2
NCT00175929UCB Pharma · epilepsyPHASE2
NCT01339559UCB BIOSCIENCES, Inc. · epilepsyPHASE3
NCT01653262UCB Pharma SA · epilepsyPHASE3
NCT01728077UCB Pharma SA · epilepsyPHASE3
NCT03405714UCB Biopharma S.P.R.L. · epilepsyPHASE2
NCT04666610UCB Biopharma SRL · epilepsyPHASE3
FDA / patent evidence
Orange Book match found; no listed patent relation was retained for this product match.
Regulatory context
FDA_APPROVALBRIVARACETAM · 2026-07-13
FDA_APPROVALBRIVARACETAM · 2026-07-13
FDA_APPROVALBRIVARACETAM · 2026-07-01
FDA_APPROVALBRIVARACETAM · 2026-02-23
FDA_APPROVALBRIVARACETAM · 2026-02-23
FDA_APPROVALBRIVARACETAM · 2026-02-23
FDA_APPROVALBRIVARACETAM · 2026-02-23
FDA_APPROVALBRIVARACETAM · 2022-10-03
FDA Orange Book coverage is U.S.-specific and is not a substitute for worldwide patent or regulatory review.